G
Genecis Bioindustries
Energy · Toronto, Canada · Founded 2016
Uses biotechnology to convert waste into high value materials, including PHA bioplastics MoreLess
Genecis Bioindustries is a climate biotechnology company focused on transforming organic waste into sustainable and biodegradable materials. Operating in the environmental and materials science sectors, Genecis serves a diverse range of clients including businesses in packaging, automotive, and textiles industries. The company’s core product is Polyhydroxyalkanoates (PHA), a biodegradable plastic alternative that offers the same functionality as traditional oil-based plastics without the associated pollution. Genecis generates revenue through partnerships with businesses interested in custom polymer formulation, rapid product development, and co-branding opportunities. The business model is centered around creating a circular economy by converting organic waste into PHA, which can then be composted and upcycled into new products at the end of their lifecycle. This approach not only addresses the growing issue of plastic waste but also provides a sustainable alternative that aligns with increasing regulatory pressures to ban single-use plastics.
Keywords: climate biotech, organic waste, biodegradable materials, circular economy, PHA, sustainable plastics, custom polymer formulation, rapid product development, co-branding, environmental innovation.
Company overview
Genecis Bioindustries company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2016
- Headquarters
- Toronto, Canada
- Employees
- 14
- Open positions
- None listed
- Dealroom signal
- 70.5
Valuation & funding
Genecis Bioindustries funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Nov 2023 | $17M | $68M | Amazon · Khosla Ventures | ↗ |
| GRANTOther financing | Jun 2023 | $150K | — | Ontario Genomics | ↗ |
| EARLY VC✓Equity / VC | Feb 2023 | $1.5M | $6M | Undisclosed | ↗ |
| DEBT✓Debt | Aug 2022 | $3M | — | Silicon Valley Bank · Standard Treasury | ↗ |
| SERIES A✓Equity / VC | Aug 2022 | $7M | $28M | AME Cloud Ventures · Gullspång Re:food · Business Development Bank of Canada · BDC Capital | ↗ |
| SEED✓Equity / VC | Oct 2021 | INP Capital · Asymmetry Ventures | — | ||
| SEED✓Equity / VC | Aug 2020 | Y Combinator | — | ||
| SEED✓Equity / VC | Apr 2020 | Sustainable Development Technology Canada · Asymmetry Ventures | — | ||
| SEED✓Equity / VC | Jun 2019 | Undisclosed | — | ||
| GRANT✓Other financing | Jan 2019 | BASF | — |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 13 |
| 2025 | 14 |
| 2024 | 16 |
| 2023 | 37 |
| 2022 | 37 |
| 2021 | 26 |
Growth signals
Genecis Bioindustries website traffic
Latest recorded traffic for Genecis Bioindustries is 150 monthly website visits, up 0% over the last three months. Genecis Bioindustries's team grew 0% over the past year.
Comparisons
Genecis Bioindustries compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Genecis Bioindustries's talent
Source: Dealroom Talent Intelligence.
Investors
30 investors on Genecis Bioindustries's cap table
Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.











Global footprint
Where Genecis Bioindustries has talent and traffic
team presence
In the news
Latest news about Genecis Bioindustries
Recent press, funding announcements, and product moves mentioning Genecis Bioindustries — open to read from the original sources.
Market sentiment
What the market is saying about Genecis Bioindustries
An AI-synthesized read of the highest-engagement posts about Genecis Bioindustries on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Genecis Bioindustries’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.






















